Premium
Angiotensin‐converting‐enzyme inhibitors versus steroids as first‐line drug treatment in Duchenne muscular dystrophy
Author(s) -
Chabrier Stéphane,
Desguerre Isabelle,
Porte Mélanie,
Payet Claude,
Rivier François
Publication year - 2010
Publication title -
developmental medicine and child neurology
Language(s) - French
Resource type - Journals
SCImago Journal Rank - 1.658
H-Index - 143
eISSN - 1469-8749
pISSN - 0012-1622
DOI - 10.1111/j.1469-8749.2010.03742.x
Subject(s) - duchenne muscular dystrophy , medicine , muscular dystrophy , ambulatory , physical therapy , pediatrics
St phane Chabrier, Isabelle Desguerre, M lanie Porte, Claude Payet, FranAois Rivier for the Neuromuscular Commission of the Soci t FranAaise de Neurologie P diatrique 1 CHU Saint-Etienne, Service de m decine physique et r adaptation p diatrique – Centre de r f rence maladies neuromusculaires Rh ne-Alpes, H pital Bellevue, Sainttienne, France. 2 Unit de neurop diatrie – Centre de r f rence maladies neuromusculaires Garches-Necker-Mondor-Hendaye, H pital Necker, Paris, France. 3 INSERM, U841 Mondor Biomedical Research Institute, Universit Paris 12, Cr teil, France. 4 CHU N mes, Service de m decine physique et r adaptation – Centre de r f rence maladies neuromusculaires du grand Sud Ouest, H pital Caremau, N mes, France. 5 CHU Montpellier, Service de neurop diatrie – Centre de r f rence maladies neuromusculaires du grand Sud Ouest, H pital Gui de Chauliac, Montpellier, France. 6 INSERM, ERI 25 'Muscle et Pathologies', Universit Montpellier 1, UFR de M decine, Montpellier, France. Correspondence to: stephane.chabrier@chu-st-etienne.fr